|
Volumn 34, Issue 1, 2009, Pages 252-253
|
Targeting the serotonin 2C receptor for the treatment of obesity and type 2 diabetes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FENFLURAMINE;
MELANOCORTIN 4 RECEPTOR;
SEROTONIN;
SEROTONIN 2B RECEPTOR;
SEROTONIN 2C AGONIST;
SEROTONIN 2C RECEPTOR;
SIBUTRAMINE;
BIOAVAILABILITY;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG SELECTIVITY;
DRUG TARGETING;
ENERGY BALANCE;
GLUCOSE HOMEOSTASIS;
HUMAN;
KNOCKOUT MOUSE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
OBESITY;
PRIORITY JOURNAL;
PROTEIN FUNCTION;
RECEPTOR AFFINITY;
SHORT SURVEY;
VALVULAR HEART DISEASE;
ANIMALS;
CLINICAL TRIALS AS TOPIC;
DIABETES MELLITUS, TYPE 2;
DRUG DELIVERY SYSTEMS;
HUMANS;
OBESITY;
RECEPTOR, SEROTONIN, 5-HT2C;
|
EID: 57649121626
PISSN: 0893133X
EISSN: None
Source Type: Journal
DOI: 10.1038/npp.2008.169 Document Type: Short Survey |
Times cited : (23)
|
References (6)
|